David R. Brenneman represents clients primarily in mergers, acquisitions, joint ventures, and civil antitrust litigation. In the merger process, David works on premerger notification under the Hart-Scott-Rodino Act, international merger control, merger investigations, second requests, and compliance with consent orders. David represents pharmaceutical, chemical, and financial services clients before the Federal Trade Commission and US Department of Justice, and he coordinates filings for multimillion- and multibillion-dollar transactions worldwide. David is a member of the Morgan Lewis Committee on Foreign Investment in the United States (CFIUS) working group.
Georgetown University Law Center, 2008, J.D.
University of Maryland, 2005, B.A.
District of Columbia
Awards and Affiliations
Recommended, Antitrust: Merger control, The Legal 500 US (2018, 2019)
Member, Practice Group of the Year, Competition, Law360 (2017, 2018)
Member, Practice Group of the Year for Antitrust, US News & World Report and Best Lawyers (2017)